Introduction:
=============

Zinc phosphide (ZnP) is a metallophosphide, dark grey and crystalline compound that is commonly used as a rodenticide due to its low cost and ease of availability ([@B1], [@B2]). ZnP poisoning could happen accidentally or intentionally as means of suicidal or homicidal attempts ([@B3]). Routes of entry into the body could be via ingestion, inhalation or through the skin. The most common clinical symptoms in poisoned cases include nausea, vomiting, abdominal pain, hypotension, metabolic acidosis, respiratory alkalosis and acute renal failure ([@B4]). Moreover, in some cases, rare complications such as acute pancreatitis, pulmonary edema, transient hyperglycemia, transient leucopenia and intravascular hemolysis may be seen ([@B5]-[@B9]). In this case report, we report a 37-year-old male patient who ingested ZnP in order to commit a suicide and faces complications due to hemolysis.

Case report
===========

A 37-year-old man with no significant past medical history was admitted to emergency ward with a history of acute ingestion of 8 packs (about 40 grams) of a dark grey, crystalline compound rodenticide in order to commit suicide. On admission, the patient was lethargic and had nausea, vomiting, abdominal pain and lacrimation with the following vital signs: blood pressure: 130/80 mmHg, pulse rate: 110 beat/minute, respiratory rate: 22 per minute, temperature: 37°C and saturation of O~2~: 92% in room air. The general physical and neurological examination was not significant. Supportive therapy was initiated and he underwent gastric lavage with %0.9 NaCl solution and activated charcoal treatment. Primary results of laboratory tests in emergency department are shown in [Table 1](#T1){ref-type="table"}. Full blood count, coagulation parameters, biochemistry, and urine analysis were in normal range and mild metabolic acidosis was reported in arterial blood gas (ABG) analysis. His electrocardiogram (ECG) only revealed sinus tachycardia.

With the impression of organophosphorus poisoning, treatment with 0.5 mg intravenous Atropine every 5 minutes and 2 grams intravenous pralydoxim every 6 hours was started. After receiving care for three days, the sclera and skin of the patient became icteric and nausea and epigastria pain increased. In Laboratory tests, hemoglobin and platelet had decreased with normal coagulation parameters ([Table 2](#T2){ref-type="table"}). Liver enzymes, serum bilirubin, creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) had increased. We started infusion of fresh frozen plasma (FFP) with diagnosis of hemolysis and diffuse intravascular coagulation (DIC). The patient underwent antioxidant therapy with N acetyl cysteine (NAC) a dose of 150 mg/kg (9 gr) in 200cc dextrose-water (DW) 5% injected in 15 minutes as loading dose, followed by 50 mg/kg (3 gr) in 500cc DW5% in 4 hours and then 100 mg/kg (6gr) in 1000cc DW5% in 16 hours as maintenance dose. In peripheral blood smear, we observed platelet aggregation and evidence of disseminated intravascular coagulation (DIC). We transfused 2 units of pack cells due to hemoglobin level being 6.4 mg/dl and it reached 9 mg/dl thereafter. Coagulation parameters also were corrected after infusion of FFP. On the ninth day of admission, the patient was stable, Lab tests became normal and the patient was referred to psychiatry service and was discharged from toxicology service.

Discussion:
===========

Phosphides (aluminum, calcium and zinc) have been used as rodenticides, but they have also been used for suicide attempts, especially in developing countries ([@B10]). A dosage of 4 to 5 grams of ZnP (55-70 mg/kg) could result in death due to acute toxicity in humans ([@B3]). The mechanism of action for ZnP is similar to aluminum phosphide as both produce toxic hydrogen phosphine (PH~3~) gas ([@B4]). When ingested, it is hydrolyzed by the gastric acid and transformed into phosphine gas, which mixes into the blood stream via the stomach and intestine vessels ([@B3], [@B5]). Phosphine inhibits cytochrome C oxidase enzyme in the respiratory chain, which leads to widespread cellular hypoxia. The direct toxic effect of phosphine on the vessel wall produces bleeding diathesis, which may lead to hemorrhage in the gastrointestinal tract, eyes and extremities ([@B11]).

###### 

Laboratory data of the patient in emergency department

  **Laboratory parameters**   **Normal range**   **Results**   **Laboratory parameters**       **Normal range**   **Results**
  --------------------------- ------------------ ------------- ------------------------------- ------------------ -------------
  BUN (mg/dl)                 5-20               17            Platelet count (\*10^3^/m^3^)   150-400            298
  Creatinine (mg/dl)          0.5-1.5            0.7           PTT (s)                         25--36 s           29
  Serum Na (mEq/l)            135-145            143           PT (s)                          11--13 s           14.7
  Serum K (mEq/l)             3.5-4.5            3.5           INR                             1-1.5              1.3
  LDH (U/L)                   225-500            273           Bilirubin (mg/dl)                                  
  CPK (U/L)                   20-200             107           Total                           0.2--1.3           0.9
  Amylase (U/L)               30-100             66            Direct                          \< 0.2             0.2
  Blood glucose (mg/dl)       70-110             116           AST (IU/L)                      11--47             38
  WBC (\*10^3^/m^3^)          4-11               9.6           ALT (IU/L)                      7--53              22
  RBC (\*10^3^/m^3^)          3.5-5.5            5.4           ALP (IU/L)                      38--126            50
  Hemoglobin (g/dL)           12.5-17.5          16.8          pH                              7.35-7.45          7.33

BUN: Blood Urea Nitrogen; LDH: Lactate dehydrogenase; CPK: Creatinine phosphokinase; WBC: White blood cells; RBC: Red blood cells; PTT: Partial thromboplastin time; PT: Prothrombin time; INR: International normalized ratio; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase

###### 

Serial laboratory results of the patient during hospitalization

  **Laboratory parameters**              **Normal range**       **12h**   **Day 1**   **Day 2**   **Day 3**   **Day 4**
  -------------------------------------- ---------------------- --------- ----------- ----------- ----------- -----------
  Serum Na                               135-145 mEq/l          136       140         138         135         138
  Serum K                                3.5-4.5 mEq/l          2.9       3.3         3           3.7         4
  Lactate dehydrogenase (LDH)            225-500 U/L            370       1325        2471        1840        768
  Creatinine phosphokinase (CPK)         20-200 U/L             450       625         706         400         68
  White blood cells (WBC)                4-11 \*10^3^/m^3^      6.4       10.1        18.4        10.2        6.6
  Red blood cells (RBC)                  3.5-5.5 \*10^6^/m^3^   3.8       2.44        3           3.5         4
  Hemoglobin                             12.5-17.5 g/dL         12.3      7.6         9           10.5        11.8
  Platelet count                         150-400 \*10^3/^m^3^   209       129         151         168         252
  Partial thromboplastin time (PTT)      25--36 s               29        31          29          28          22
  Prothrombin time (PT)                  11--13 s               14.7      20          16.1        12.7        12.4
  International normalized ratio (INR)   1-1.5                  1.3       3.9         1.3         1.5         1
  Total bilirubin                        0.2--1.3 mg/dL         20        31.7        15.5        4.2         3.3
  Direct bilirubin                       \</0.2 mg/dL           7.9       20          8.5         2.5         1.9
  Aspartate aminotransferase (AST)       11--47 IU/L            200       235         180         60          25
  Alanine aminotransferase (ALT)         7--53 IU/L             190       163         131         82          70
  Alkaline phosphatase (ALKP)            38--126 IU/L           572       656         429         409         372
  pH                                     7.35-7.45              7.58      7.51        7.45        7.5         7.41
  PCO~2~                                 33-45 mmHg             32        37.9        38          36.2        35.3
  HCO~3~                                 22-28 mEq/L            30.8      34.8        35.1        30.9        28.1

Clinical symptoms are severe hypotension, myocarditis, pericarditis, acute pulmonary edema, gastrointestinal symptoms (nausea, vomiting and diarrhea), metabolic acidosis, congestive heart failure and acute kidney failure. Moreover, retrosternal pain, shortness of breath, cyanosis, liver failure, severe hypoglycemia, delirium and tonic-colonic seizure may occur ([@B12]).

Currently, there is no known specific antidote for phosphine gas poisoning; so a high mortality rate (range 37 to 100%) is seen among people who are poisoned with it ([@B5]). The treatment for ZnP poisoning is supportive and symptomatic. There is a controversy regarding use of activated charcoal, but it is recommended to give a dose of it to the patient on admission as soon as possible ([@B13]). When standard conservative treatment fails, the only option to save the life of a ZnP-poisioned patient with irreversible acute liver failure is liver transplantation ([@B14]). Some reports have shown the benefits of using NAC in patients with hepatic damage due to phosphine poisoning, so we treated our patient with NAC ([@B15]).

Jaundice due to hepatic damage or intravascular hemolysis may also occur in organophosphorus toxicity ([@B16], [@B17]). In our patient, after 3 days of admission, jaundice started and developed due to intravascular hemolysis and acute hepatic failure as evident through indirect hyperbilirubinemia, elevated liver enzymes, reticulocytosis, hemolytic anemia, and the presence of schistocyte in peripheral blood smear. In some cases, hemolysis occurs due to G6PD deficiency but in our case, G6PD level was normal ([@B18], [@B19]). Our patient had denied exposure to any other drug, including hemolytic agents, and had not received any such drug during his hospital stay. In one study, morphological changes in erythrocytes were reported following *in vitro*incubation with PH~3~gas. However, all cells displayed crenation, and no hemolysis or Heinz body formation was noted, thus it is unlikely that hemolysis can be related to the direct effect of PH~3~ on the red blood cells ([@B20]).

Our patient initially came to emergency ward with gastrointestinal symptoms (nausea and vomiting), decreased level of consciousness, and metabolic acidosis. We observed him and started conservative therapy. After 3 days, intravascular hemolysis and liver failure were initiated. We continued supportive care until his liver enzymes became normal and hemolysis was stopped.

Conclusion:
===========

In patients poisoned with ZnP, jaundice may occur due to hepatic damage, but it can also result from intravascular hemolysis.
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